Exact Sciences Corporation

NasdaqCM:EXAS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

💊 Pharmaceuticals

🔍 Research & Consulting

💻 Software & Operating Systems

Location

United States

Market Cap

USD 7.75 B

Share Price

USD 40.91

Avg Daily Volume

3,118,320

Change (1 day)

-0.19%

Change (1 year)

-28.24%

Change (YTD)

-27.19%

Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2025: USD -818.55 M

Exact Sciences Corporation EBITDA is USD -818.55 M for the Trailing 12 Months (TTM) ending June 30, 2025, a -1,298.44% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 68.30 M, a -131.75% change year over year.
Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -215.10 M, a -58.25% change year over year.
Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2022 was USD -515.19 M, a -40.07% change year over year.
Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -859.66 M, a 353.87% change year over year.